Effect of interventions to improve the use of inhalers as instructed by the health care provider

ISRCTN ISRCTN13994441
DOI https://doi.org/10.1186/ISRCTN13994441
Secondary identifying numbers JIP/IEC/2015/15/571
Submission date
21/10/2021
Registration date
01/11/2021
Last edited
11/11/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Taking medications (or other treatment) exactly as instructed by a health care provider (adherence) is the key to the success of any treatment. It is well established that adherence in chronic diseases is low, in the range of 30-70%. The adherence rate is much lower for inhalers compared to other dosage forms. Non-adherence leads to inadequate disease control and increased healthcare cost. Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) is a Government of India-funded health care centre. JIPMER is the only institution that provides dry powder inhalers (Rotahaler) and rotacaps free of cost to treat patients with CRDs. Hence, it attracts patients not only from Puducherry, but also from the neighbouring districts of Tamil Nadu. These drugs are prescribed to about 1,000 patients every month. Both the Rotahaler and the beclomethasone dipropionate rotacaps are among the high-priced drugs procured in JIPMER. However, there is no policy to check the correct use of these drugs and the proper inhaler technique among these patients. This work studies the adherence to inhalers among patients with CRDs, the correct use of the inhaler, and enhance adherence through counselling and reminders through mobile phones.

The aim is to assess the effectiveness of sending reminders through mobile phones and patient counselling to improve adherence among patients with chronic respiratory disease using inhalers in a tertiary care centre in Puducherry.

Who can participate?
Adult patients with the diagnosis of asthma or COPD being followed in JIPMER Medicine or Pulmonary Medicine Outpatient Department and using the inhaler for at least three months at the time of recruitment to the study. Both male and female patients aged from 14 to 80 years with or without other co-morbid conditions were included in the study. Patients should own a mobile phone.

What does the study involve?
Patient counselling and recorded voice call reminders were the two interventions tested to improve adherence. Patients were randomized into four groups. Group 1 received both interventions, group 2 received patient counselling alone, group 3 received voice call reminders alone and group 4 received usual treatment. All groups received baseline treatment, i.e., teaching on inhaler technique.

What are the possible benefits and risks of participating?
Patients gain knowledge about the disease and drug. Improved adherence leads to better disease control and improved quality of life. Since no new treatments or drugs were involved in the trial, no new side effects were expected. No risks were involved in participating in the study.

Where is the study run from?
JIPMER (India)

When is the study starting and how long is it expected to run for?
May 2015 to December 2019

Who is funding the study?
JIPMER Intramural Fund (India)

Who is the main contact?
Manjulakshmi Padmanabhan, manjulakshmi.p@gmail.com

Contact information

Ms Manjulakshmi P Padmanabhan
Public

E-41 JIPMER campus
Danvantri Nagar
Gorimedu
Puducherry
605006
India

ORCiD logoORCID ID 0000-0002-9831-0669
Phone +90 (0)7598376368
Email manjulakshmi.p@gmail.com

Study information

Study designSingle-center interventional 2x2 factorial randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Participant information sheet No participant information sheet available
Scientific titleThe effect of interventions to improve adherence to inhaled medications in patients with chronic respiratory diseases
Study objectivesSending reminders to mobile phones and patient counselling to improve adherence among patients with chronic respiratory disease using inhalers in a tertiary care centre in Puducherry were effective
Ethics approval(s)Approved 28/05/2015, Institute Ethics Committee Human Studies, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER, JIPMER Campus Road, Gorimedu, Dhanvantari Nagar, Puducherry 605006, India; +091-0413-2298288; research@jipmer.edu.in), ref: ECR/342/Inst/PY/2013
Health condition(s) or problem(s) studiedAsthma and chronic obstructive pulmonary disease (COPD)
InterventionPatients were randomized into four groups. Group 1 received both interventions, group 2 received patient counselling alone, group 3 received voice call reminders alone and group 4 received usual treatment. All groups received baseline treatment, i.e., teaching on inhaler technique.

Control: Patients were shown a video explaining the technique of inhaler use. This video was downloaded from YouTube (https://www.youtube.com/watch? v=fVPKNl2tNu4) with the title “Learn how to use a Rotahaler Inhale” on demonstration of Rotahaler that M/s Cipla uploaded. This video explains the steps in the use of Rotahaler. After watching the video, patients were asked to demonstrate the technique. Any steps that were missed or done incorrectly were rectified on the spot.

Patient counselling: This involves face-to-face counselling with the recruited patients in groups 1 and 2. This counselling focuses on clarifying patients’ beliefs about disease, which were identified as barriers to adherence. The topics to be discussed during patient counselling were identified by semi-structured interviews conducted before the start of the study. In brief, the topics discussed were:
(1) The disease process in chronic respiratory diseases (CRD) and its chronic nature
(2) The role of allergy in asthma and their belief about food-induced allergy. The role of smoking in COPD patients
(3) The need to take drugs regularly
(4) The need to follow a healthy lifestyle with balanced nutrition and exercise
(5) Any other doubts the patients may raise were also clarified

Voice call reminders: Patients in groups 1 and 3 received recorded voice calls. A recorded voice call message was sent twice a week to their mobile phones in their vernacular language, encouraging them to take their medications regularly. The message was for 20 seconds. Voice call messages would advise patients to take their steroids (red rotacaps) regularly and a note to contact their healthcare provider in case of uncontrolled disease.

Randomization:
A randomization table was created using the Random Allocation Software. A computer-generated randomized sequence was made by a person not involved in the study. These were placed in sequentially numbered opaque sealed envelopes and handed over to the investigator. This was used for randomizing the patients to one of the four treatment groups.
Intervention typeBehavioural
Primary outcome measureSelf-reported adherence measured using 8-item Morisky Medication Adherence Questionnaire at baseline, third month and sixth month.
Secondary outcome measures1. Prescription refill data measured using the proportion of days covered at six months before intervention and six months during the intervention
2. Severity of disease measured using lung capacity (FEV1(%)) at baseline, third month and sixth month
Overall study start date28/05/2015
Completion date20/12/2019

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants440
Total final enrolment421
Key inclusion criteria1. Patients diagnosed with asthma or COPD and followed up in JIPMER Medicine or Pulmonary Medicine outpatient department, three months prior to the study period with or without other co-morbid conditions
2. The patients should own a mobile phone and be able to use it
Key exclusion criteria1. Patients who should refrain from performing PFT, as in the case of patients with pneumothorax, history of recent MI or pulmonary embolism, abdominal or cerebral aneurysm
2. Patients who had undergone recent surgery
3. Patients who were hard of hearing or mentally disabled
Date of first enrolment20/03/2017
Date of final enrolment10/06/2019

Locations

Countries of recruitment

  • India

Study participating centre

Jawaharlal Institute of Postgraduate Medical Education and Research
JIPMER Campus Road
Gorimedu
Dhanvantari Nagar
Gorimedu
Puducherry
605006
India

Sponsor information

Jawaharlal Institute of Post Graduate Medical Education and Research
University/education

JIPMER Campus Road
Dhanvantari Nagar
Gorimedu
Puducherry
605006
India

Phone +91-0413-2298288
Email research@jipmer.edu.in
Website http://jipmer.edu.in/
ROR logo "ROR" https://ror.org/02fq2px14

Funders

Funder type

University/education

Jawaharlal Institute Of Postgraduate Medical Education and Research
Government organisation / Local government
Alternative name(s)
JIPMER
Location
India

Results and Publications

Intention to publish date01/05/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe principal investigator is willing the share the de-identified participant level data.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other files Case report form 27/10/2021 No No
Protocol file 27/10/2021 No No

Additional files

40572 Protocol.pdf
40572 CRF.pdf
Case report form

Editorial Notes

11/11/2022: The intention to publish date was changed from 01/01/2022 to 01/05/2023.
27/10/2021: Trial's existence confirmed by Institute Ethics Committee Human Studies, Jawaharlal Institute of Postgraduate Medical Education and Research.